Basic Study
Copyright ©The Author(s) 2016.
World J Hepatol. Apr 8, 2016; 8(10): 499-508
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.499
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Tyrosine predicts 3-mo liver transplant-free survival in patients with end-stage liver disease. Results are presented as AUC (P25, P75). AUC: Area under receiver operating characteristics curve; OLT: Orthotopic liver transplantation; MELD: Model for end-stage liver disease.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Tyrosine predicts 6-mo liver transplant-free survival in patients with end-stage liver disease. AUC: Area under receiver operating characteristics curve; OLT: Orthotopic liver transplantation; MELD: Model for end-stage liver disease.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Citrulline and betaine serve as diagnostic biomarkers in patients with alcoholic hepatitis. AUC: Area under receiver operating characteristics curve.